Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. Read more about Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial. Read more about Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.
Risk Stratification for Second Primary Lung Cancer. Read more about Risk Stratification for Second Primary Lung Cancer.
Response Assessment in Neuro-Oncology Clinical Trials. Read more about Response Assessment in Neuro-Oncology Clinical Trials.
Diffuse Infiltrating Oligodendroglioma and Astrocytoma. Read more about Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. Read more about Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Active Surveillance in Younger Men With Prostate Cancer. Read more about Active Surveillance in Younger Men With Prostate Cancer.
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. Read more about Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies. Read more about Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies.
Relevance of American Society of Clinical Oncology Value Framework Will Be Improved if It Is Based on Network Meta-Analyses. Read more about Relevance of American Society of Clinical Oncology Value Framework Will Be Improved if It Is Based on Network Meta-Analyses.
